SCHEMBL557796

SCHEMBL557796

CC(C)CN(CCO)CC(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
CYP1A2 P05177 2/20 0.40
MAPK1 P28482 2/20 0.40
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PIK3CD O00329 1/20 0.32
SLC29A1 Q99808 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339998 0.94 MAPT (0.45) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL9641431 0.90 MAPT (0.38) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL12039759 0.87 ALDH1A1 (0.43) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL7931178 0.87 CYP1A2 (0.43) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL3427669 0.85 MAPT (0.38) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL7933716 0.85 CYP1A2 (0.39) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL556846 0.83 CYP1A2 (0.37) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL27859031 0.83 MAPT (0.36) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL4290820 0.83 MAPT (0.36) MAPTCYP1A2MAPK1CA12CA1
SCHEMBL1551622 0.81 CYP1A2 (0.36) MAPTCYP1A2MAPK1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4455176-A1 WATER-SOLUBLE POLYMERIC STRUCTURE AND WATER-SOLUBLE POLYMERIC STRUCTURE PREPARATION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-10-30 EP claimed
US-20220363976-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES CHAMPIONX LLC 2022-11-17 US claimed
EP-3208659-A1 COMPOSITION FOR RESIST PATTERNING AND METHOD FOR FORMING PATTERN USING SAME AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2017-08-23 EP claimed
US-20170219927-A1 COMPOSITION FOR RESIST PATTERNING AND METHOD FOR FORMING PATTERN USING SAME AZ ELECTRIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) 2017-08-03 US claimed
US-20150367277-A1 Alkanolamine-Based Carbon Dioxide Absorbent Containing Polyalkylene Glycol Monomethyl Ether, and Carbon Dioxide Absorption Method and Separation Method Using Same UNIVERSITY-INDUSTRY COOPERATION FOUNDATION OF KYUNG HEE UNIVERSITY (KR) 2015-12-24 US claimed
EP-4549621-A1 PROCESS FOR MAKING AMINES FROM ALCOHOLS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY BASF SE (DE) 2025-05-07 EP disclosed
WO-2025013801-A1 COATING COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM 東ソー株式会社 2025-01-16 WO disclosed
EP-4455176-A1 WATER-SOLUBLE POLYMERIC STRUCTURE AND WATER-SOLUBLE POLYMERIC STRUCTURE PREPARATION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-10-30 EP disclosed
CN-117866209-A Polyether modified polysiloxane and preparation method thereof, and polyether modified polysiloxane defoamer and preparation method thereof 科之杰新材料集团有限公司 2024-04-12 CN disclosed
CN-117777461-A Polyether modified polysiloxane and preparation method thereof, and organic silicon defoamer and preparation method thereof 科之杰新材料集团有限公司 2024-03-29 CN disclosed
CN-117777464-A Polyether modified polysiloxane and preparation method thereof, efficient defoamer and preparation method thereof 科之杰新材料集团有限公司 2024-03-29 CN disclosed
US-20230312412-A1 LIMESTONE CALCINED CLAY CEMENT (LC3) CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2023-10-05 US disclosed
EP-0009154-B1 COMPLEXES OF 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITIONS CONTAINING THE COMPLEXES AS ACTIVE INGREDIENTS Newport Pharmaceuticals International, Inc. (US) 1982-12-08 EP disclosed
EP-0009155-B1 9-HYDROXYALKYL-PURINES, PROCESSES FOR PREPARING THEM AND THERAPEUTICAL COMPOSITION CONTAINING THE 9-HYDROXYALKYL-PURINES AS ACTIVE INGREDIENTS Newport Pharmaceuticals International, Inc. (US) 1982-11-17 EP disclosed
US-4223138-A VAPORIZATION, CONDENSATION, RETARDING FLOW TO REACTION ZONE BAYER AKTIENGESELLSCHAFT (DE) 1980-09-16 US disclosed
US-4221910-A IMMUNOPOTENTIATORS, VIRICIDES, ANTILEUKEMIA AGENTS NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) 1980-09-09 US disclosed
US-4221909-A P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1980-09-09 US disclosed
US-4221794-A Method of imparting immunomodulating and antiviral activity NEWPORT PHARMACEUTICALS INTERNATIONAL, INC. (US) 1980-09-09 US disclosed
EP-0009155-A1 9-Hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients Newport Pharmaceuticals International, Inc. (US) 1980-04-02 EP disclosed
EP-0009154-A1 Complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients Newport Pharmaceuticals International, Inc. (US) 1980-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363976-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES HDHD5, HACL2, ADH5 MAPT 4096/4885CYP1A2 375/4885MAPK1 4768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.